These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19414846)

  • 1. Clinically relevant prognostic markers for prostate cancer: the search goes on.
    Gelmann EP; Henshall SM
    Ann Intern Med; 2009 May; 150(9):647-9. PubMed ID: 19414846
    [No Abstract]   [Full Text] [Related]  

  • 2. New prognostic factors in prostatic carcinoma.
    Visakorpi T; Kallioniemi OP; Koivula T; Isola J
    Eur Urol; 1993; 24(4):438-49. PubMed ID: 8287885
    [No Abstract]   [Full Text] [Related]  

  • 3. New biomarkers for diagnosis and prognosis of localized prostate cancer.
    Chistiakov DA; Myasoedova VA; Grechko AV; Melnichenko AA; Orekhov AN
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):9-16. PubMed ID: 29360504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study.
    Kim SH; Park WS; Park BR; Joo J; Joung JY; Seo HK; Chung J; Lee KH
    Asian J Androl; 2017; 19(4):458-462. PubMed ID: 27232854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latest UK figures show increase in prostate cancer diagnoses and falling death rate.
    Mayor S
    BMJ; 2012 May; 344():e3252. PubMed ID: 22569872
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromogranin A as a biomarker for prostate cancer: is it actually relevant for clinical practice?
    Appetecchia M; Lauretta R; Sperduti I; Gallucci M
    Future Oncol; 2018 Jun; 14(13):1233-1235. PubMed ID: 29712494
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular markers and death from prostate cancer.
    Concato J; Jain D; Uchio E; Risch H; Li WW; Wells CK
    Ann Intern Med; 2009 May; 150(9):595-603. PubMed ID: 19414838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for evaluation of prostate cancer prognosis.
    Esfahani M; Ataei N; Panjehpour M
    Asian Pac J Cancer Prev; 2015; 16(7):2601-11. PubMed ID: 25854335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta hCG as a prognostic marker in prostatic adenocarcinoma.
    Furness P
    J Clin Pathol; 1996 Aug; 49(8):693-4. PubMed ID: 8881932
    [No Abstract]   [Full Text] [Related]  

  • 10. Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis.
    Troyer DA; Mubiru J; Leach RJ; Naylor SL
    Dis Markers; 2004; 20(2):117-28. PubMed ID: 15322319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of molecular biology in detection and monitoring of prostate cancer.
    Zummerová A; Böhmer D; Fillo J; Danihel L; Repiská V
    Cesk Patol; 2010 Oct; 46(4):95-7. PubMed ID: 21309265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for prostate cancer.
    Schiffer E
    World J Urol; 2007 Dec; 25(6):557-62. PubMed ID: 17690889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!
    Collette L; Buyse M; Burzykowski T
    J Clin Oncol; 2007 Dec; 25(35):5673-4; author reply 5674. PubMed ID: 18065747
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarkers in prostate cancer - Current clinical utility and future perspectives.
    Kretschmer A; Tilki D
    Crit Rev Oncol Hematol; 2017 Dec; 120():180-193. PubMed ID: 29198331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic markers in clinically localised prostate cancer.
    Bai XZ; Masters JR; O'Donoghue N; Kirby R; Pan LX; Young M; Stafford M; Parkinson MC
    Int J Oncol; 1999 Apr; 14(4):785-91. PubMed ID: 10087330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative biomarkers for prostate cancer early diagnosis and progression.
    You J; Cozzi P; Walsh B; Willcox M; Kearsley J; Russell P; Li Y
    Crit Rev Oncol Hematol; 2010 Jan; 73(1):10-22. PubMed ID: 19328712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and immunologic diagnosis of cancer. Prostatic cancer.
    Malkin A
    Tumour Biol; 1987; 8(2-3):113-5. PubMed ID: 2452468
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic biomarkers in early-stage prostate cancer.
    Klein E
    Clin Adv Hematol Oncol; 2017 Jan; 15(1):43-45. PubMed ID: 28212369
    [No Abstract]   [Full Text] [Related]  

  • 19. Apoptosis-related markers for predicting progression of prostate cancer.
    Yu DS
    J Chin Med Assoc; 2007 Jan; 70(1):3. PubMed ID: 17276925
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of radioimmunoanalysis for tumor markers in the diagnosis of carcinoma of the testes and prostate].
    Kausitz J
    Bratisl Lek Listy; 1988 Oct; 89(10):715-24. PubMed ID: 2463063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.